U.S. Pledges Up to $2.1 Billion for Sanofi, GlaxoSmithKline Covid Vaccine
U.S. President Donald Trump speaks during an event on the South Lawn of the White House in Washington, D.C., U.S. (Photographer: Al Drago/Bloomberg)

U.S. Pledges Up to $2.1 Billion for Sanofi, GlaxoSmithKline Covid Vaccine

Bookmark
(Bloomberg) -- The Trump administration will provide as much as $2.1 billion to Covid-19 vaccine partners Sanofi and GlaxoSmithKline Plc, the biggest U.S. investment yet in fast-tracking shots and ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.